Johannes Bras

2.1k citations
36 papers · 980 indexed · h-index 19
Topics
Sarcoma Diagnosis and Treatment (17 papers)Bone Tumor Diagnosis and Treatments (8 papers)Vascular Tumors and Angiosarcomas (5 papers)

In The Last Decade

Johannes Bras

36 papers receiving 960 citations

Peers

Johannes Bras
Comparison fields: 5 of 72
  • Pulmonary and Respiratory Medicine 387
  • Molecular Biology 339
  • Oncology 304
  • Rheumatology 234
  • Surgery 187
Replace Toshiro Fukuda with:
Toshiro Fukuda Japan
Tomoya Matsunobu Japan
Helene Sjögren Sweden
Josephine Issakov Israel
Bernarda Kazanowska Poland
Hiroo Yabe Japan
Jun Nishio Japan
José J. Navas‐Palacios Spain
Chandrika Sreekantaiah United States
Yuko Ohjimi Japan
Johannes Bras relative to Toshiro Fukuda Japan Toshiro Fukuda's profile →
Citations per field
00.5×4.1×
Toshiro Fukuda · 1×
Citations per year

Countries citing papers authored by Johannes Bras

Since Specialization
Citations

This map shows the geographic impact of Johannes Bras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Bras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Bras more than expected).

Fields of papers citing papers by Johannes Bras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Bras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Bras. The network helps show where Johannes Bras may publish in the future.

Co-authorship network of co-authors of Johannes Bras

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Bras. A scholar is included among the top collaborators of Johannes Bras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Bras. Johannes Bras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 28
2 6
3 8
4 34
5 19
6 9
7 12
8 60
9 4
10 11
11 19
12 32
13 19
14 20
15 11
16 29
17 64
18 83
19 14
20 11

About Johannes Bras

Johannes Bras is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Hematology, having authored 36 papers that have together received 980 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (17 papers), Bone Tumor Diagnosis and Treatments (8 papers) and Vascular Tumors and Angiosarcomas (5 papers). The work is most often cited by research in Rheumatology (234 citations), Pulmonary and Respiratory Medicine (387 citations) and Oncology (304 citations). Johannes Bras has collaborated with scholars based in Netherlands, Sweden and United States. Frequent co-authors include Theo J.M. Hulsebos, Johannes H. M. Merks, Rick R. van Rijn, Frank Baas, Gerard R. Schaap, Thomas Mentzel, Uta Flucke, Albert J.H. Suurmeijer, David Creytens and Nicolas de Saint Aubain Somerhausen. Their work appears in journals such as Circulation, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026